This survey study of clinicians with clinical trial experience in LMICs suggests that adequate funding and a well-trained research workforce are 2 predominant challenges to advancing cancer therapeutic clinical trials in LMICs. Understanding these obstacles can inform efforts to support cancer clinical trials that better reflect worldwide needs and diversity by prioritizing and sustaining research led by LMIC investigators.
Building similarity graph...
Analyzing shared references across papers
Loading...
Linsey Eldridge
National Cancer Institute
Nina R. Goodman
National Institutes of Health
A. Chtourou
National Institutes of Health
JAMA Network Open
National Institutes of Health
National Cancer Institute
Indiana University – Purdue University Indianapolis
Building similarity graph...
Analyzing shared references across papers
Loading...
Eldridge et al. (Mon,) studied this question.
synapsesocial.com/papers/69d6e65af174babf6cab3b40 — DOI: https://doi.org/10.1001/jamanetworkopen.2025.7733
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: